Shares of Cardinal Health, Inc. (NYSE:CAH – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eighteen research firms that are covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $247.80.
Several research analysts recently weighed in on the stock. Wells Fargo & Company dropped their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday. Bank of America increased their price target on Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Zacks Research lowered Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Finally, William Blair assumed coverage on Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating for the company.
Check Out Our Latest Stock Analysis on Cardinal Health
Institutional Inflows and Outflows
Cardinal Health Stock Performance
Shares of NYSE:CAH opened at $239.36 on Wednesday. The business has a fifty day moving average of $210.43 and a 200-day moving average of $212.35. Cardinal Health has a twelve month low of $137.75 and a twelve month high of $243.21. The firm has a market cap of $56.06 billion, a PE ratio of 36.60, a price-to-earnings-growth ratio of 1.17 and a beta of 0.49.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the prior year, the firm earned $2.35 EPS. The company’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts anticipate that Cardinal Health will post 10.76 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is presently 31.50%.
Cardinal Health Company Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Read More
- Five stocks we like better than Cardinal Health
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
